Literature DB >> 25479121

High-resolution(18)F-fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for pituitary adenoma detection in Cushing disease.

Prashant Chittiboina1, Blake K Montgomery, Corina Millo, Peter Herscovitch, Russell R Lonser.   

Abstract

OBJECT High-resolution PET (hrPET) performed using a high-resolution research tomograph is reported as having a resolution of 2 mm and could be used to detect corticotroph adenomas through uptake of(18)F-fluorodeoxyglucose ((18)F-FDG). To determine the sensitivity of this imaging modality, the authors compared(18)F-FDG hrPET and MRI detection of pituitary adenomas in Cushing disease (CD). METHODS Consecutive patients with CD who underwent preoperative(18)F-FDG hrPET and MRI (spin echo [SE] and spoiled gradient recalled [SPGR] sequences) were prospectively analyzed. Standardized uptake values (SUVs) were calculated from hrPET and were compared with MRI findings. Imaging findings were correlated to operative and histological findings. RESULTS Ten patients (7 females and 3 males) were included (mean age 30.8 ± 19.3 years; range 11-59 years). MRI revealed a pituitary adenoma in 4 patients (40% of patients) on SE and 7 patients (70%) on SPGR sequences.(18)F-FDG hrPET demonstrated increased(18)F-FDG uptake consistent with an adenoma in 4 patients (40%; adenoma size range 3-14 mm). Maximum SUV was significantly higher for(18)F-FDG hrPET-positive tumors (difference = 5.1, 95% CI 2.1-8.1; p = 0.004) than for(18)F-FDG hrPET-negative tumors.(18)F-FDG hrPET positivity was not associated with tumor volume (p = 0.2) or dural invasion (p = 0.5). Midnight and morning ACTH levels were associated with(18)F-FDG hrPET positivity (p = 0.01 and 0.04, respectively) and correlated with the maximum SUV (R = 0.9; p = 0.001) and average SUV (R = 0.8; p = 0.01). All(18)F-FDG hrPET-positive adenomas had a less than a 180% ACTH increase and(18)F-FDG hrPET-negative adenomas had a greater than 180% ACTH increase after CRH stimulation (p = 0.03). Three adenomas were detected on SPGR MRI sequences that were not detected by(18)F-FDG hrPET imaging. Two adenomas not detected on SE (but no adenomas not detected on SPGR) were detected on(18)F-FDG hrPET. CONCLUSIONS While(18)F-FDG hrPET imaging can detect small functioning corticotroph adenomas and is more sensitive than SE MRI, SPGR MRI is more sensitive than(18)F-FDG hrPET and SE MRI in the detection of CD-associated pituitary adenomas. Response to CRH stimulation can predict(18)F-FDG hrPET-positive adenomas in CD.

Entities:  

Keywords:  ACTH = adrenocorticotropic hormone; CD = Cushing disease; CRH = corticotropin-releasing hormone; Cushing disease; IPSS = inferior petrosal sinus sampling; SE = spin echo; SPGR = spoiled gradient recalled; SUV = standardized uptake value; SUVAvg = average SUV; SUVMax = maximum SUV; hrPET = high-resolution PET; magnetic resonance imaging; pituitary adenoma; pituitary surgery; positron emission tomography

Mesh:

Substances:

Year:  2014        PMID: 25479121      PMCID: PMC5091074          DOI: 10.3171/2014.10.JNS14911

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  19 in total

1.  HRRT versus HR+ human brain PET studies: an interscanner test-retest study.

Authors:  Floris H P van Velden; Reina W Kloet; Bart N M van Berckel; Fred L Buijs; Gert Luurtsema; Adriaan A Lammertsma; Ronald Boellaard
Journal:  J Nucl Med       Date:  2009-04-16       Impact factor: 10.057

2.  Outcome of using the histological pseudocapsule as a surgical capsule in Cushing disease.

Authors:  Jay Jagannathan; Rene Smith; Hetty L DeVroom; Alexander O Vortmeyer; Constantine A Stratakis; Lynnette K Nieman; Edward H Oldfield
Journal:  J Neurosurg       Date:  2009-09       Impact factor: 5.115

3.  Calculating the tumor volume of acoustic neuromas: comparison of ABC/2 formula with planimetry method.

Authors:  Yi-Lin Yu; Meei-Shyuan Lee; Chun-Jung Juan; Dueng-Yuan Hueng
Journal:  Clin Neurol Neurosurg       Date:  2013-02-01       Impact factor: 1.876

4.  Spoiled gradient recalled acquisition in the steady state technique is superior to conventional postcontrast spin echo technique for magnetic resonance imaging detection of adrenocorticotropin-secreting pituitary tumors.

Authors:  Nicholas Patronas; Nail Bulakbasi; Constantine A Stratakis; Antony Lafferty; Edward H Oldfield; John Doppman; Lynnette K Nieman
Journal:  J Clin Endocrinol Metab       Date:  2003-04       Impact factor: 5.958

5.  Transsphenoidal surgery for Cushing's disease: outcome in patients with a normal magnetic resonance imaging scan.

Authors:  P L Semple; M L Vance; J Findling; E R Laws
Journal:  Neurosurgery       Date:  2000-03       Impact factor: 4.654

6.  Incidental pituitary uptake on whole-body 18F-FDG PET/CT: a multicentre study.

Authors:  Shin Young Jeong; Sang-Woo Lee; Hui Joong Lee; Sungmin Kang; Ji-Hyoung Seo; Kyung Ah Chun; Ihn Ho Cho; Kyung Sook Won; Seok Kil Zeon; Byeong-Cheol Ahn; Jaetae Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-07-27       Impact factor: 9.236

7.  Volume interpolated 3D-spoiled gradient echo sequence is better than dynamic contrast spin echo sequence for MRI detection of corticotropin secreting pituitary microadenomas.

Authors:  Rajeev Kasaliwal; Shilpa S Sankhe; Anurag R Lila; Sweta R Budyal; Varsha S Jagtap; Vijaya Sarathi; Harshal Kakade; Tushar Bandgar; Padmavathy S Menon; Nalini S Shah
Journal:  Clin Endocrinol (Oxf)       Date:  2013-04-06       Impact factor: 3.478

8.  Management of Cushing's disease: outcome in patients with microadenoma detected on pituitary magnetic resonance imaging.

Authors:  Daniel M Prevedello; Nader Pouratian; Jonathan Sherman; John A Jane; Mary Lee Vance; M Beatriz Lopes; Edward R Laws
Journal:  J Neurosurg       Date:  2008-10       Impact factor: 5.115

9.  The diagnostic value of fused positron emission tomography/computed tomography in the localization of adrenocorticotropin-secreting pituitary adenoma in Cushing's disease.

Authors:  Ali S Alzahrani; Rafif Farhat; Abdullah Al-Arifi; Nora Al-Kahtani; Imad Kanaan; Mohei Abouzied
Journal:  Pituitary       Date:  2009-04-22       Impact factor: 4.107

10.  Detection of pituitary microadenomas: comparison of dynamic keyhole fast spin-echo, unenhanced, and conventional contrast-enhanced MR imaging.

Authors:  W Kucharczyk; J E Bishop; D B Plewes; M A Keller; S George
Journal:  AJR Am J Roentgenol       Date:  1994-09       Impact factor: 3.959

View more
  13 in total

Review 1.  iMRI During Transsphenoidal Surgery.

Authors:  Prashant Chittiboina
Journal:  Neurosurg Clin N Am       Date:  2017-08-18       Impact factor: 2.509

Review 2.  Cushing's Syndrome in Pediatrics: An Update.

Authors:  Maya B Lodish; Margaret F Keil; Constantine A Stratakis
Journal:  Endocrinol Metab Clin North Am       Date:  2018-06       Impact factor: 4.741

Review 3.  Metabolic In Vivo Visualization of Pituitary Adenomas: a Systematic Review of Imaging Modalities.

Authors:  Amy Yao; Priti Balchandani; Raj K Shrivastava
Journal:  World Neurosurg       Date:  2017-04-28       Impact factor: 2.104

Review 4.  PET imaging in ectopic Cushing syndrome: a systematic review.

Authors:  Prasanna Santhanam; David Taieb; Luca Giovanella; Giorgio Treglia
Journal:  Endocrine       Date:  2015-07-25       Impact factor: 3.633

5.  CRH stimulation improves 18F-FDG-PET detection of pituitary adenomas in Cushing's disease.

Authors:  Jacqueline Boyle; Nicholas J Patronas; James Smirniotopoulos; Peter Herscovitch; William Dieckman; Corina Millo; Dragan Maric; Grégoire P Chatain; Christina Piper Hayes; Sarah Benzo; Gretchen Scott; Nancy Edwards; Abhik Ray Chaudhury; Maya B Lodish; Susmeeta Sharma; Lynnette K Nieman; Constantine A Stratakis; Russell R Lonser; Prashant Chittiboina
Journal:  Endocrine       Date:  2019-05-06       Impact factor: 3.633

6.  Corticotropin releasing hormone can selectively stimulate glucose uptake in corticotropinoma via glucose transporter 1.

Authors:  Jie Lu; Blake K Montgomery; Grégoire P Chatain; Alejandro Bugarini; Qi Zhang; Xiang Wang; Nancy A Edwards; Abhik Ray-Chaudhury; Marsha J Merrill; Russell R Lonser; Prashant Chittiboina
Journal:  Mol Cell Endocrinol       Date:  2017-10-03       Impact factor: 4.102

7.  Potential utility of FLAIR in MRI-negative Cushing's disease.

Authors:  Grégoire P Chatain; Nicholas Patronas; James G Smirniotopoulos; Martin Piazza; Sarah Benzo; Abhik Ray-Chaudhury; Susmeeta Sharma; Maya Lodish; Lynnette Nieman; Constantine A Stratakis; Prashant Chittiboina
Journal:  J Neurosurg       Date:  2017-10-13       Impact factor: 5.115

8.  The combination of 13N-ammonia and 11C-methionine in differentiation of residual/recurrent pituitary adenoma from the pituitary gland remnant after trans-sphenoidal Adenomectomy.

Authors:  Fangling Zhang; Qiao He; Ganhua Luo; Yali Long; Ruocheng Li; Lei Ding; Xiangsong Zhang
Journal:  BMC Cancer       Date:  2021-07-20       Impact factor: 4.430

Review 9.  Approach to the Treatment of a Patient with an Aggressive Pituitary Tumor.

Authors:  Andrew L Lin; Mark T A Donoghue; Sharon L Wardlaw; T Jonathan Yang; Lisa Bodei; Viviane Tabar; Eliza B Geer
Journal:  J Clin Endocrinol Metab       Date:  2020-12-01       Impact factor: 5.958

10.  Selective resection of cushing microadenoma guided by preoperative hybrid 18-fluoroethyl-L-tyrosine and 11-C-methionine PET/MRI.

Authors:  Sven Berkmann; Michel Roethlisberger; Beat Mueller; Mirjam Christ-Crain; Luigi Mariani; Egbert Nitzsche; Freimut Juengling
Journal:  Pituitary       Date:  2021-06-21       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.